Dr. Reem Salah Hanna, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2300 Freeport Rd, Suite 6 Feldarelli Square, New Kensington, PA 15068 Phone: 724-335-6611 Fax: 724-335-3711 |
News Archive
Cambridge Antibody Technology today announced that it is starting a Phase I clinical trial of CAT-354, a human anti-IL-13 monoclonal antibody, which is a potential treatment for severe asthma, following recent approval from the Medicines and Healthcare products Regulatory Agency (MHRA).
Justin E. Bekelman, M.D., of the University of Pennsylvania Perelman School of Medicine, Philadelphia, and colleagues conducted a study to examine whether single-fraction radiation treatment, shown to be as effective as multiple-fraction treatment with less potential for harm, has been incorporated into routine clinical practice for Medicare beneficiaries with prostate cancer and at what cost savings.
Today's headlines include details about today's health law repeal vote in the House. It comes just as lawmakers prepare to leave for the August break.
In both cell cultures and mouse models, a drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus - and blocked transmission of the virus to mouse fetuses.
Today, The National Toxicology Program released its Report on Carcinogens, which included the substance styrene. The following statement on the safety of foodservice packaging products made from polystyrene can be attributed to Cal Dooley, CEO of the American Chemistry Council.
› Verified 2 days ago